Protective neutralizing epitopes in SARS‐CoV‐2

The COVID‐19 pandemic has caused an unprecedented health crisis and economic burden worldwide. Its etiological agent SARS‐CoV‐2, a new virus in the coronavirus family, has infected hundreds of millions of people worldwide. SARS‐CoV‐2 has evolved over the past 2 years to increase its transmissibility...

Full description

Saved in:

Bibliographic Details
Published in:	Immunological reviews Vol. 310; no. 1; pp. 76 - 92
Main Authors:	Liu, Hejun, Wilson, Ian A.
Format:	Journal Article
Language:	English
Published:	England Wiley Subscription Services, Inc 01.09.2022 John Wiley and Sons Inc
Subjects:	Antibodies antibody coronavirus Coronaviruses COVID-19 epitope Epitopes Immune response Immune system Infections Invited Review Neutralizing Pandemics SARS‐CoV‐2 SARS‐CoV‐2 Vaccines Severe acute respiratory syndrome Severe acute respiratory syndrome coronavirus 2 vaccine variants Viral diseases Viral infections Viruses coronavirus SARS-CoV-2 vaccine antibody variants epitope
ISSN:	0105-2896, 1600-065X, 1600-065X
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!